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          Ames dwarf mice demonstrate delayed aging processes in multiple body systems.  
We compared muscle composition and area between dwarf and wild-type mice to 
determine if any significant differences exist. 
Methods.   
          We resected soleus, gastrocnemius/plantaris, tibialis anterior, and extensor 
digitorum longus muscles from both dwarf and wild-type mice, then froze, sliced, set on 
slides, and stained to isolate fast-twitch and slow-twitch fibers.  Microscopy images were 
taken at 10x magnification and fiber composition and cross-sectional area were measured 
in soleus muscles. 
Results  
          Wild-type mice had an average composition of 52.3% fast-twitch and 47.7% slow-
twitch fibers while dwarf mice had 66.3% slow-twitch and 33.7% fast-twitch fibers.  
Differences between fast- and slow-twitch composition of dwarfs and fast-twitch and 
slow-twitch composition of 12-month-old wild-type versus dwarfs all yielded statistical 
significance.  Dwarf mice had a smaller cross-sectional area than both 3-month and 12-




          Dwarfs demonstrated smaller muscle fiber area than wild-type mice, which was not 
surprising as dwarf mice have an innately slighter stature than wild-types.  Wild-type 
mice, with a higher ratio of fast-twitch fibers, would exhibit higher rates of myosin 
ATPase hydrolysis and muscular strength, while dwarf mice, with more slow-twitch 












 Sarcopenia translates from the Greek words “sarco-“, meaning “flesh”, and “-
penia”, meaning “deficiency.”  Cruz-Jentoft et al1 give: “Sarcopenia is a syndrome 
characterised by progressive and generalised loss of skeletal muscle mass and strength 
with a risk of adverse outcomes such as physical disability, poor quality of life and 
death.”  There are no known certain causes of sarcopenia, but there are many theories, 
including chemical, mechanical, and nervous system changes.  Baumgartner et al² 
suggest tissue secretion changes, decreased responsiveness to trophic hormones, diet and 
metabolism changes, disuse atrophy or selective atrophy of type II fibers which contract 
and relax more quickly and allow greater generation of force than type I fibers, and 
decreased innervation and blood supply may play a role in age-related muscle loss.  
Although it is commonly accepted that muscle mass decreases with age, the rate of 
decline is unknown.  Vandervoort and McComas³ tested ankle musculature strength in 
young, middle aged, and elderly men and women and found that plantarflexor and 
dorsiflexor strength, specifically, began to decrease around the 6th decade of life and then 
declined at a rate of 1.3% per year.  Rantanen et al4 found a 1% per year decrease in grip 
strength in Japanese-American males over a 27-year period; initial ages ranged from 45 
to 68 years old.  A steeper decline in strength (i.e. greater than 1.5% per year) was 
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positively correlated with older baseline age, greater weight decrease over the follow-up 
period, and presence of comorbidities such as stroke, diabetes, chronic obstructive 
pulmonary disease (COPD), or heart disease.  Doherty5 examined numerous studies and 
calculated an average of 20% to 40% less overall strength for healthy individuals in the 
7th and 8th decades of life versus younger adults.  The difference increased to 50% for 
those in their 9th decade and older.  Kallman et al6 used grip strength and estimated 
muscle mass of individuals between the ages of 20 and 100 to determine loss of strength 
from both a longitudinal and cross-sectional view.  They found that, on average, both 
variables peaked in the 4th decade (much earlier than the findings of Vandervoort and 
McComas) and then began to decline thereafter.  Over the 9 year follow-up period, 
however, 48% of individuals under age 40, 29% between 40 and 59 years old, and 15% 
aged 60 and older did not show any decrease in grip strength.  The decreasing percentage 
of individuals without loss of strength as age increases could support the idea of 
increased presence of sarcopenia with increased age.   
 The results of Gallagher et al7 support this idea of strength loss with age.  They 
found a significant decrease in total appendicular skeletal muscle in both men and women 
after a follow-up of an average 4.7 years.  However, in men, body weight showed no 
significant change while fat mass significantly increased.  Both body weight and fat mass 
decreased in women, but was not significant.  Weight loss is often used as a measure of 
sarcopenia in the elderly, but this study suggests that this may not be a reliable means. 
 As physical therapists, our primary concern for all patients is functional ability.  
Theoretically, the loss of muscle mass would lead to loss of muscle strength and decline 
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of function. Cress and Meyer8 evaluated peak oxygen consumption (Vo2peak) and 
isokinetic knee extensor torque (KET) values for men and women ages 65 to 97 and 
compared it to their physical function using the Continuous-Scale Physical Function 
Performance test (CS-PFP) which scores 16 different household tasks with various units 
of measurement (time, distance, etc) to determine level of function.  They then analyzed 
whether their scores could predict independent living.  Two groups lived independently, 
either as community-dwellers or in a congregate care facility with little to no functional 
limitation, and the dependent group lived in a congregate care facility with significant 
functional limitation.  They found that the “threshold” values for Vo2peak (20 mL/kg/min) 
and KET (2.5 N·m/[kg/m]) correlated with a CS-PFP score of 57 units (maximum score = 
100 units).  All participants with CS-PFP scores above 57 lived independently, while 
only 57% of participants with scores under 57 lived independently.  According to 
ElderCare,9 the cost of an assisted living facility ranges from $25,000 to $50,000 a year.  
Medicare does not provide any financial assistance, though Medicaid may pay part of the 
cost of services in some states.  Prevention and treatment of individuals with sarcopenia 
may prevent this financial burden on patients and their families.  For instance, physical 
therapy treatment for strengthening, endurance, and balance 2 times per week for 4 weeks 
twice a year would cost approximately $1,060.  If this is able to be covered by insurance, 
this could reduce costs to the patient as well as Medicare. 
  Lauretani et al10 compared differences in isometric muscle strength, calf cross-
sectional area, walking ability, and walking speed in 1,030 individuals between the ages 
of 20 and 102 to determine prevalence of sarcopenia.  Presence was defined as a score of 
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2 standard deviations below the average value for the 20 to 29 year old age group of the 
same gender.  Strength and muscle mass were further analyzed as potential predictors of 
mobility limitations.  They found that muscle strength declined considerably with age and 
was strongly associated with factors of poor mobility (walking ability and speed).  
Muscle mass (calf cross-sectional area), however, declined much less rapidly than 
strength and was not consistently associated with mobility limitations.  Based on their 
findings, the authors suggest that loss of muscle strength should be considered in 
conjunction with loss of muscle mass when defining sarcopenia.  Janssen et al11 
compared muscle mass to functional impairments in older adults.  They measured muscle 
mass using bioimpedance, a living organism or tissue’s response to electrical current, and 
expressed it as skeletal muscle mass index or SMI (skeletal muscle mass/body mass x 
100).  Class I sarcopenia was defined as an SMI between 1 standard deviation above and 
2 standard deviations below the average score for individuals between 18 and 39 years 
old of the same sex; class II sarcopenia was a score greater than 2 standard deviations 
below the reference average.  The authors found that the likelihood of functional 
impairment was 2 to 3 times more for older men and women with class II sarcopenia than 
for similar-aged individuals with a normal SMI.  They also reported an increase in both 
classes of sarcopenia from the 3rd to 6th decades of life with no increase afterward.  This 
is in agreement with the previously discussed findings of Kallman et al,6 but conflicts 
with Vandervoort and McComas,3 who found that loss of muscle strength, sarcopenia, 
did not begin until the 6th decade and then further declined.  This may suggest that newer 
research (studies conducted in 2002 and 1986, respectively) has found that onset of 
sarcopenia occurs earlier than previously thought.  Therefore, sarcopenia intervention 
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could be beneficial during early to middle adulthood to prevent or slow the decline of 
muscle mass and strength and to maintain function. 
 Age is not the only predictive factor for sarcopenia being researched.  Ogawa et 
al12 studied the correlation of extracellular heat shock protein (eHsp72) with age in 665 
men and women.  In general, Hsps act as a “molecular chaperone” to protect cell 
proteomes by recognizing damaged proteins and directing them to either a repair or 
proteolytic pathway.  These Hsps degenerate with age due to time and decreased 
resistance of oxidants in the body.  Protection of motor neurons in particular is associated 
with eHsp72 so, hypothetically, degradation of this protein could lead to decreased 
protection of neurological muscle function and decreased muscle mass.  They found that 
higher plasma eHsp72 levels were significantly positively correlated with decreased 
muscle mass, grip strength, and walking speed.  These findings indicate that eHsp72 may 
potentially be used as a biomarker for sarcopenia in the elderly population.  Visser et al13 
found that, based on both grip strength and skeletal muscle mass, low levels of 25-
hydroxyvitamin D (25-OHD) and high levels of parathyroid hormone (PTH) were 
associated with higher risk of sarcopenia in both men and women over the age of 65.  The 
authors defined sarcopenia as being in the lowest 15th percentile of the sex-specific 
cohort; equal to a 40% or greater loss in grip strength and a 3% or greater loss in muscle 
mass.  The more that is known about the significant risk factors for sarcopenia, the 
greater the chances of early detection and prevention of functional limitations or 
disability due to weakness. 
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 The Ames dwarf mice, which exhibit increased longevity and delayed aging 
compared to their wild-type counterparts, lack growth hormone (GH), prolactin (PRL), 
and thyroid-stimulating hormone (TSH).  Bartke and Brown-Borg14 suggest that the 
absence of GH in these mice reduces the synthesis of insulin-like growth factor 1, 
secretion of insulin, plasma glucose levels, production of reactive oxygen species, and 
oxidative damage while increasing glucose sensitivity of the liver, antioxidant defenses, 
and resistance to oxidative stress.  We decided to use the Ames dwarf mouse to assess 
any difference in fiber size and the composition of fast twitch (type II) versus slow twitch 
(type I) muscle fibers due to these hormonal differences and their apparent resistance to 















 The surgical procedure to collect the hindlimb muscles of the mice was performed 
with the animals under anesthesia.  We used 100 μL/10g body weight of 2.5% 
tribromoethanol in 0.9% saline solution utilizing an intraperitoneal injection.  Adequate 
sedation was determined by checking pain reflexes: squeezing feet and eliciting corneal 
reflex.  The first incisions were made around the leg at the ankles to release the skin and a 
slit was made proximally to allow us to peel the skin up to the hip.  The heel cord was cut 
to free the insertion of the gastrocnemius, plantaris, and soleus.  The soleus was then 
separated and removed from the gastroc/plantaris.  Then the gastroc/plantaris complex 
was removed from its attachment at the knee.  The tibialis anterior (TA) was separated 
from the tibia, then freed from the ankle and the proximal leg.  Finally, the extensor 
digitorum longus (EDL) was cut at the ankle and the knee.  All muscles were weighed 
and measured, placed on a piece of liver from a wild-type mouse, covered with optimal 
cutting temperature (OCT) compound, and frozen in isopentane in liquid nitrogen.  The 
muscles were stored in liquid nitrogen at -80˚C until we were ready for slicing. 
 We used a Cryostat at -25˚C for slicing the muscle tissue.  The blade was first 
cleaned with alcohol then allowed to cool in the Cryostat for 30 minutes.  The tissue 
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samples were also kept in the Cryostat to increase their temperature to -25˚C.  The tissues 
were then mounted with OCT vertically onto the chuck, trimmed in 50μm sections until 
muscle tissue was seen, and then further trimmed in 10μm sections for 50 slices.  
Collection of slices began at this point with 30 consecutive sections (3 sections per slide), 
50 sections discarded, etc. until the end of the bulk of each muscle was reached.  The 
slides used were Fisherbrand Superfrost Plus Microscope slides (Thermo Fisher 
Scientific, Waltham, MA).  Slides containing tissue samples were stored at -20˚C. 
 Following collection of the tissue samples, slides were stained with hematoxylin 
and eosin for measurement of cross-sectional area.  The slides were removed from the 
freezer and allowed to dry.  They were set in Harris hematoxylin for 2 minutes, then 
rinsed twice in distilled water. We dipped them 3 times in acid alcohol (11 mL glacial 
acetic acid, 95 mL ethanol, 5 mL distilled water), rinsed them in distilled water, dipped 
them 6 times in ammonium water (0.625 mL 25% ammonium hydroxide, 250 mL 
distilled water), followed by another rinse in distilled water.  The slides were then put in 
the working eosin solution (62.5 mL stock eosin, 187.5 mL 80% ethanol, 1.56 mL glacial 
acetic acid) for 30 seconds, rinsed in distilled water twice, and dehydrated in ethanol at 
70%, 95%, and 100% for 15 seconds each.  Each slide was cleared in xylene and 
mounted with a slipcover in Permount.  The newly mounted slides were stored at room 
temperature. 
 Tissue samples used for comparison of fast versus slow twitch fibers were stained 
for myosin heavy chains.  Slides were brought to room temperature and a PAP pen was 
used to encircle the tissues.  One slide was used as a control.  All slides were rinsed in 1X 
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Phosphate Buffered Saline (PBS) for 2 minutes then laid into a Pyrex® dish.  H2O2/horse 
serum was added to slides for 5 minutes, then rinsed in PBS twice for 2 minutes.   
 We used the Avidin/Biotin Blocking Kit15 (Vector Labs, Burlingame, CA) to 
block avitin binding sites and biotin receptors from staining; the Mouse on Mouse 
(M.O.M.) Peroxidase Kit16 (Vector Labs, Burlingame, CA) to isolate specific proteins 
(fast twitch and slow twitch antibodies), improve distinction between primary and 
secondary proteins and antibodies to reduce background staining, and reduce unwanted 
binding of secondary antibodies to mouse tissue immunoglobulin; and the DAB 
Peroxidase Substrate Kit17 (3,3’-diaminobenzidine) to produce a visible reaction with the 
isolated antibodies. 
 The slides were set with avidin blocking solution and biotin blocking solution for 
15 minutes each with a 2 minute PBS rinse between and after the solutions.  Then, they 
were incubated in IgG blocking reagent in a covered, humid Pyrex® dish for 1 hour.  All 
slides were rinsed in PBS for 2 minutes before incubating in protein concentrate for 5 
minutes.  Slides were then separated into 2 groups for fast and slow twitch stains: MOM 
diluents + slow antibody and MOM diluents + fast antibody.  The control slide did not 
receive any antibody stain.  The groups were incubated in their respective primary 
antibody dilutions for 30 minutes then rinsed twice in PBS for 2 minutes.  All slides 
(including control) were incubated in MOM Biotinylated Anti-Mouse IgG Reagent for 10 
minutes.  Two PBS rinses for 2 minutes each were performed, then the slides were 
incubated in Reagent A+B mix for 5 minutes after the mix was allowed to set for 30 
minutes.  Slides received 2 more 2-minute PBS rinses then incubated in DAB solution for 
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10 minutes.  Finally, all slides were rinsed in distilled water for 1 minute, dehydrated in 
alcohol for 2 dips each in 70%, 95%, and 100%, and dehydrated in xylene.  Coverslips 
were applied, using a Permount solution, and laid flat overnight to dry.  Slides were 



















 Microscopy (10x) images of well-sliced, -mounted, and –stained slides were 
obtained for analysis.  We compared counts of stained and unstained cells for fast twitch 
and slow twitch stained slides between the following: 3- vs. 12-month-old wild-type 
mice, 3- vs. 12-month-old dwarf mice, 3-month-old wild-type vs. dwarf mice, and 12-
month-old wild-type vs. dwarf mice.  Due to human error, lack of researcher experience, 
and the large amount of variability in the cutting, mounting, and staining of each tissue 
slice, total cell counts varied between images from the same tissue.  Some cells could 
have been stained more than once or not at all and the borders of many cells were not 
well-defined.  We decided to convert all the cell counts to percentages for a more logical 
comparison.  Fast twitch-stained left soleus muscle slices of a 3-month-old wild-type 
mouse contained 48.5% stained (fast twitch) and 51.5% unstained cells; slow twitch-
stained slices from the same tissue contained 45.6% unstained and 54.4% stained (slow 
twitch) cells.  Fast twitch-stained right soleus muscle slices of a 12-month-old wild-type 
mouse had 62.2% stained (fast twitch) and 37.8% unstained cells; slow twitch-stained 
slices showed 52.8% unstained and 47.2% stained (slow twitch) cells, a considerable 
difference between staining conditions.  Fast twitch-stained soleus muscle slices of two 
dwarf mice yielded 31.3% and 35.5% stained (fast twitch) and 68.7% and 64.5% 
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unstained cells; slow twitch-stained slices of the same muscles had 36.5% and 31.5% 
unstained and 63.5% and 68.5% stained (slow twitch) cells.  The results are outlined in 
Table 1.  Independent of age, wild-type mice had a higher percentage of fast twitch 
muscle cells than dwarf mice and dwarf mice had a greater percentage of slow twitch 
cells than wild-type mice. 
 We used Scion Image to measure the cross-sectional areas of muscle fibers of a 3-
month wild-type mouse soleus, 12-month wild-type mouse soleus, and 6-month dwarf 
mouse soleus.  Unpaired t-test comparison using QuickCalcs online software18 between 
wild-type mice revealed a slightly greater cross-sectional area in the 3-month samples 
versus 12-month samples, but this was not significant.  The 6-month dwarf samples had a 
significantly smaller area than both ages of the wild-type mice.  Detailed results are 
available in Table 2.   
 Two-sample t-tests were used to compare fast-twitch versus slow-twitch cell 
percentage in 3-month-old wild-type, 12-month-old wild-type, and 6-month-old dwarf 
mice with SISA online software.19  Statistically significant differences were found 
between fast and slow-twitch fiber composition of both dwarf samples, fast-twitch fiber 
percentage between 12-month-old wild-type and both dwarf samples, and slow-twitch 
fiber percentage between 12-month-old wild-type and one dwarf sample.  Table 3 






Table 1. Fast twitch versus slow twitch fiber composition comparison in dwarf and wild-
type mice 
 3 fast L sol n2 3 slow L sol n2  12 fast R sol n4 12 slow R sol n4 
stained 231 249  181 153 
unstained 245 209  110 171 
      
total 476 458  291 324 
      
% stained 0.485 0.544  0.622 0.472 
% unstained 0.515 0.456  0.378 0.528 
      
 Fast sol d1 Slow sol d1  Fast sol d2 Slow sol d2 
stained 109 235  194 387 
unstained 239 135  352 178 
      
total 348 370  546 565 
      
% stained 0.313 0.635  0.355 0.685 




Table 2. Cross-Sectional area comparison of soleus muscles of dwarf and wild-type mice 
Age, Muscle, Mouse Type 3 H&E L Sol N2 12 H&E R Sol N4 6 H&E Sol D1 
 2471.01 2246 808.43 
 2665.32 2181 778.29 
 2087.57 3484 484.23 
 2238.25 3415 457.21 
 3387.5 1695 659.84 
 3598.44 1621 653.6 
 2339.04 1357 871.81 
 2344.23 1347 841.68 
 2519.84 3386 814.66 
 2744.29 3307 788.69 
    






Table 3. Statistical analysis summary 
Cross-Sectional 
Area 
     
 3mo N 12mo N 6mo D   
M 2639.55 2403.9 715.84   
SD 491.77 905.06 147.29   
SEM 155.51 286.2 46.58   
N 10 10 10   
      
 3mo N vs 
12mo N 
3mo N vs 
6mo D 
12mo N vs 
6mo D 
  
P value 0.4787 <0.0001* <0.0001*   
Mean Difference 235.65 1923.71 1688.06   







t value 0.72 11.85 5.82   
df 18 18 18   
SED 325.73 162.34 289.97   
      
      
Cell Count      
 3mo         
F vs S 
12mo       
F vs S 
d1           
F vs S 
d2           
F vs S 
 
P value 0.5608 0.1516 0.001* 0.0012*  
 F            
3 vs 12mo 
F            
3mo vs d1 
F         
12mo. vs d1 
F            
3mo vs d2 
F         
12mo. vs d2 
P value 0.193 0.0542 0.0014* 0.1562 0.007* 
 S            
3 vs 12mo 
S            
3mo vs d1 
S          
12mo vs d1 
S            
3mo vs d2 
S          
12mo vs d2 
P value 0.4752 0.402 0.1214 0.2036 0.0478* 
M = mean, SD = standard deviation, SEM = standard error of the mean, N = sample size, 
P = probability, CI = confidence interval, t = mean difference relative to its standard 
deviation, df = degrees of freedom, SED = standard error of difference between two 











 The 3-month-old and 12-month-old wild-type mice had almost opposite 
percentages of muscle cell types, which correlates with the decrease in fast-twitch muscle 
fibers seen in humans as they age.20  We were unable to obtain viable images for 3-month 
and 12-month dwarf mice for comparison, so we cannot determine any changes in muscle 
composition with age.  This would have allowed us to compare rates of change of fast-
twitch and slow-twitch fiber composition between wild-type and dwarf mice to provide 
evidence of a “slowed” aging process in the musculoskeletal system of dwarves.   
 Area difference between dwarf and normal mice was unsurprising as dwarfs are 
inherently smaller than normal wild-type mice.  Again, images of 3-month and 12-month 
dwarves were unable to be obtained, so we cannot make any conclusions regarding 










 Dwarf mice had a higher percentage of slow twitch muscle fibers, a lower 
percentage of fast twitch fibers, and a smaller average cross-sectional area than wild-type 
mice of both ages.  Based on muscle composition, wild-type mice have greater strength 
and increased myosin ATPase hydrolysis, while dwarf mice have higher endurance and 
greater oxidative capacity.  This may be due to a number of factors and more research 
will need to be done to determine causation.  An inherently greater composition of slow-
twitch muscle fibers could possibly delay the aging process in dwarf mice as there are 
fewer fast-twitch fibers in which degeneration may occur.  Dwarfs are naturally smaller 
than wild-type mice, but because we were unable to make a comparison among dwarf 
mice of different ages, we cannot examine differences between dwarfs and normal mice 
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